Latest News
Hershey: The Bear Case Just Melted, I'm Upgrading To Bullish While Yielding 3.32%
I am upgrading The Hershey Company to bullish, citing cocoa deflation, improved logistics, and strong execution. HSY delivered a Q2 double beat, raised full-year guidance, and now trades at 17.7x 2027
Macy's: The Tariff Refund Nobody Has Modeled
Macy's remains a Buy due to undervaluation, strong free cash flow yield, and ongoing turnaround signals. Q2 guidance targets $4.75B–$4.8B revenue, 6.9%–7.2% adj. EBITDA margin and 29–34 cents adj. EPS
Interactive Brokers: Buy On Weakness, Not At The Highs
Interactive Brokers is rated a Buy after pulling back about 7 to 10 percent from its all-time high, making an already strong compounder more reasonably priced. Second quarter results were strong, with
$10,000 invested in SpaceX stock 2 months ago is now worth
Investors who bought SpaceX (NASDAQ: SPCX) stock during the August recovery rally have yet to fully recover their losses despite a strong rebound over the past month.
NVDX: Good Set-Up For A Leveraged Play On Nvidia Stock
The T-REX 2X Long NVIDIA Daily Target ETF remains a Buy after delivering a 250% total return over 2.5 years. NVDX achieves 2x daily exposure to NVDA via swap agreements, not by holding the underlying
Buy 2 Enhanced Yield Hedges And Sleep Like A Baby
The current bull rally in equities, driven by massive AI CapEx, feels increasingly late-cycle and vulnerable to a correction. I see parallels between today's AI investment surge and past capital misal
Replenish Nutrients CEO talks major scale-up - ICYMI
Replenish Nutrients Holding Corp (CSE:ERTH, OTC:VVIVF, FRA:7KE) earlier this week outlined how its strategic relationship with Spanish River Carbonatite (SRC) could support a significant production sc
Northwest Natural Holding: Regulated Utilities Is Where It's At
Northwest Natural Holding has executed a successful multi-year pivot, aggressively diversifying into water, wastewater, and Texas gas utilities. NWN's capital deployment has driven PP&E to $3.8B, a 7.
PRCT Deadline: PRCT Investors with Losses in Excess of $100K Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit
NEW YORK, Sept. 5, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) between February 28
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and deserve attention.
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Taboola.com Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TBLA
New York, New York--(Newsfile Corp. - September 5, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Taboola.com Ltd. (NASDAQ: TBLA) between May 6, 20
Micron: Nothing Is Over Yet
Micron Technology, Inc. remains a Buy as consolidation offers a compelling entry point with improved valuation and robust medium-term earnings visibility. Bearish concerns around AI memory demand comp
August Jobs Report: Rate Hike Indicated, But Maybe Just One
August's robust labor market data likely paves the way for a Fed rate hike in September, with unemployment steady at 4.1% and payrolls up 162k. Despite strong jobs and consumption data, rising jobless
Merchants Bancorp's Rally Is Testing How Much Risk Investors Will Overlook
Few regional banks had a year as dramatic as Merchants Bancorp NASDAQ: MBIN and still managed to keep a Buy rating from analysts. The parent of Merchants Bank of Indiana has swung from a credit scare
Affleck and Aflac. It was only a matter of time.
The long-awaited partnership brings Ben Affleck and the Aflac Duck together on screen for the first time in a series of advertisement spots directed by Affleck. COLUMBUS, Ga.
BioAge: CV Risk Data Due H2 A Major Catalyst After Rival's Data Causes Sell-Off
BioAge Labs remains a buy despite a >40% stock drop, as the recent sell-off appears overblown given competitive Phase 1 data for BGE-102. BGE-102, a best-in-class NLRP3 inhibitor, achieved up to 98% I
Bitcoin: Supply Crunch Is Real, So Is The Exit Risk
Bitcoin faces key resistance near $82,800, but I am bullish with a 12-month target of $95,000 and a stop-loss at $74,000. ETF inflows hit $3.52 billion in August, signaling institutional macro hedging
CAPR CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Capricor Investors of Securities Class Action Lawsuit Deadline on September 28, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Capricor To Contact Him Directly To Discuss Their Options If you purchased or acquire
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Alarum Technologies Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ALAR
New York, New York--(Newsfile Corp. - September 5, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Alarum Technologies Ltd. (NASDAQ: ALAR) between M
TYG: This Fund Sacrifices A Lot Of Performance For The Yield
Tortoise Energy Infrastructure Corp. offers a 13.27% yield but has significantly underperformed both the energy sector and peer funds year-to-date. TYG's portfolio has significant exposure to electric